Palatin Tech To Present At The 36th Annual Canaccord Genuity Growth Conference
CRANBURY, N.J., Aug. 8, 2016 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, announced today that Carl Spana, the Company's President & Chief Executive Officer, will present at the 36th Annual Canaccord Genuity Growth Conference on Thursday, August 11th, 2016 at 1:00 p.m. Eastern time. The conference is being held at the InterContinental Boston, Boston, MAAugust 10-11, 2016.
About Palatin Technologies
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at http://www.palatin.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/palatin-technologies-to-present-at-the-36th-annual-canaccord-genuity-growth-conference-300310390.html
SOURCE Palatin Technologies, Inc.
